{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:18:25Z","timestamp":1785410305734,"version":"3.56.0"},"reference-count":34,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,12]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Risk factors for recurrent venous thromboembolism (VTE) in children are poorly understood, and concerns remain about the risks of anticoagulant therapy in children. This single-center cohort with nested case-control study aimed to determine the incidence rate of recurrent thrombosis and associated risk factors and the incidence of major bleeding in children with VTE on therapeutic anticoagulation. We identified 632 patients managed for VTE between 1 January 2015 and 31 December 2022. The recurrence rate of VTE was 13.7 per 100 person-years. Univariate analysis showed the presence of a central venous catheter (CVC; P = .02), inflammatory bowel disease (IBD; P = .02), and intestinal failure (P = .03) were significant risk factors for recurrent VTE. In multivariate logistic regression, significant risk factors for recurrence were anatomic venous abnormality (odds ratio [OR], 2.8; 95% confidence interval [CI], 1.37-5.59), presence of a CVC (OR, 2.0; 95% CI, 1.21-3.26), and IBD (OR, 3; 95% CI, 1.18-7.98). Major bleeding on anticoagulation occurred at a rate of 2.2 per 100 person-years. These data demonstrate that this heterogeneous cohort of children had a high risk of VTE recurrence. The overall major bleeding risk with anticoagulation was low. Although each patient with VTE needs to be considered individually, these data support the view that perceived bleeding risk should generally not be a major barrier to anticoagulation in the pediatric setting. Moreover, secondary or extended anticoagulation may be considered in children at high risk for recurrence.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016135","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T15:13:58Z","timestamp":1744816438000},"page":"3824-3831","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Recurrent thrombosis and major bleeding in children treated for VTE"],"prefix":"10.1182","volume":"9","author":[{"given":"Stephanie F.","family":"Lenahan","sequence":"first","affiliation":[{"name":"1Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Blackmore","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-9601","authenticated-orcid":false,"given":"Matthew","family":"Fenchel","sequence":"additional","affiliation":[{"name":"2Division of Biostatistics and Epidemiology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Thomas","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7550-8532","authenticated-orcid":false,"given":"Joseph S.","family":"Palumbo","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH"},{"name":"3Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0283-9972","authenticated-orcid":false,"given":"Cristina","family":"Tarango","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH"},{"name":"3Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"5","key":"2025081210014406100_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1067\/mpd.2001.118192","article-title":"Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands","volume":"139","author":"van Ommen","year":"2001","journal-title":"J Pediatr"},{"key":"2025081210014406100_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpeds.2016.02.017","article-title":"Incidence trends and mortality from childhood venous thromboembolism: a population-based cohort study","volume":"172","author":"Sabapathy","year":"2016","journal-title":"J Pediatr"},{"issue":"4","key":"2025081210014406100_bib3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jpeds.2011.03.052","article-title":"Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study","volume":"159","author":"Tuckuviene","year":"2011","journal-title":"J Pediatr"},{"issue":"3","key":"2025081210014406100_bib4","doi-asserted-by":"crossref","first-page":"e2021054649","DOI":"10.1542\/peds.2021-054649","article-title":"The continued rise of venous thromboembolism across US children's hospitals","volume":"149","author":"O'Brien","year":"2022","journal-title":"Pediatrics"},{"issue":"4","key":"2025081210014406100_bib5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1542\/peds.2009-0768","article-title":"Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007","volume":"124","author":"Raffini","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"2025081210014406100_bib6","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jtha.2023.03.004","article-title":"Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis","volume":"21","author":"Whitworth","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"suppl 1","key":"2025081210014406100_bib7","first-page":"S63","article-title":"Predicting the risk of venous thromboembolism recurrence","volume":"87","author":"Heit","year":"2012","journal-title":"Am J Hematol"},{"key":"2025081210014406100_bib8","doi-asserted-by":"crossref","first-page":"l4363","DOI":"10.1136\/bmj.l4363","article-title":"Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis","volume":"366","author":"Khan","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"2025081210014406100_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/hematology.2020002268","article-title":"Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?","volume":"2020","author":"\u00c1inle","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"2025081210014406100_bib10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE","volume":"83","author":"Andrew","year":"1994","journal-title":"Blood"},{"issue":"6","key":"2025081210014406100_bib11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1203\/00006450-200006000-00013","article-title":"Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry","volume":"47","author":"Monagle","year":"2000","journal-title":"Pediatr Res"},{"issue":"2","key":"2025081210014406100_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/jama.2021.23182","article-title":"Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous thromboembolism: the Kids-DOTT randomized clinical trial","volume":"327","author":"Goldenberg","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"2025081210014406100_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jtha.2022.11.031","article-title":"High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism","volume":"21","author":"Whitworth","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2025081210014406100_bib14","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","article-title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial","volume":"7","author":"Male","year":"2020","journal-title":"Lancet Haematol"},{"issue":"1","key":"2025081210014406100_bib15","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/S2352-3026(20)30368-9","article-title":"Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b\/3, non-inferiority trial","volume":"8","author":"Halton","year":"2021","journal-title":"Lancet Haematol"},{"issue":"3","key":"2025081210014406100_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood.2021013453","article-title":"Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis","volume":"139","author":"Clark","year":"2022","journal-title":"Blood"},{"issue":"6","key":"2025081210014406100_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/pbc.20728","article-title":"May-Thurner syndrome (iliac vein compression) and thrombosis in adolescents","volume":"47","author":"Raffini","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"2025081210014406100_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpeds.2018.11.018","article-title":"Treatment-related outcomes in Paget-Schroetter syndrome-a cross-sectional investigation","volume":"207","author":"Kumar","year":"2019","journal-title":"J Pediatr"},{"issue":"3","key":"2025081210014406100_bib19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1358863X241240427","article-title":"Deep venous thrombosis in patients with atresia of the inferior vena cava and right kidney hypoplasia (KILT syndrome): systematic review of the literature","volume":"29","author":"Pantic","year":"2024","journal-title":"Vasc Med"},{"issue":"2","key":"2025081210014406100_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26785","article-title":"Inferior vena cava atresia predisposing to acute lower extremity deep vein thrombosis in children: a descriptive dual-center study","volume":"65","author":"Tarango","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2025081210014406100_bib21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.thromres.2015.01.032","article-title":"Congenital abnormalities of the inferior vena cava presenting clinically in adolescent males","volume":"135","author":"Halparin","year":"2015","journal-title":"Thromb Res"},{"issue":"8","key":"2025081210014406100_bib22","doi-asserted-by":"crossref","first-page":"e606","DOI":"10.1016\/S2352-3026(24)00138-8","article-title":"Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational study","volume":"11","author":"Bravo-P\u00e9rez","year":"2024","journal-title":"Lancet Haematol"},{"key":"2025081210014406100_bib23","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izae249","article-title":"The risk of venous thromboembolism in children with inflammatory bowel disease","author":"Harvey","year":"14  2024","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"2025081210014406100_bib24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S2352-4642(24)00078-6","article-title":"Rare and severe adverse events in children with inflammatory bowel disease: analysis of data from the PIBD-SETQuality Safety Registry","volume":"8","author":"Klomberg","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"issue":"5","key":"2025081210014406100_bib25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ecco-jcc\/jjab171","article-title":"The incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease: a prospective international cohort study based on the PIBD-SETQuality Safety Registry","volume":"16","author":"Aardoom","year":"2022","journal-title":"J Crohns Colitis"},{"issue":"5","key":"2025081210014406100_bib26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/MPG.0000000000003078","article-title":"Venous thromboembolism in pediatric inflammatory bowel disease: a case-control study","volume":"72","author":"Mitchel","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"suppl 2","key":"2025081210014406100_bib27","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines [published correction appears in Chest. 2014;146(6):1694]","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"issue":"2","key":"2025081210014406100_bib28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3324\/haematol.10616","article-title":"A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin: a prospective cohort study","volume":"92","author":"Kuhle","year":"2007","journal-title":"Haematologica"},{"issue":"5","key":"2025081210014406100_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood.2019001847","article-title":"Treatment of venous thromboembolism in pediatric patients","volume":"135","author":"Witmer","year":"2020","journal-title":"Blood"},{"issue":"3","key":"2025081210014406100_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MPG.0000000000003200","article-title":"A European survey on digestive perianastomotic ulcerations, a rare Crohn-like disorder occurring in children and young adults","volume":"73","author":"Madre","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"2025081210014406100_bib31","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jemermed.2021.12.006","article-title":"Severe coagulopathy in a patient with short bowel syndrome","volume":"62","author":"Saito","year":"2022","journal-title":"J Emerg Med"},{"issue":"2","key":"2025081210014406100_bib32","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/ajcn\/nqz110","article-title":"Clinical outcomes in pediatric intestinal failure: a meta-analysis and meta-regression","volume":"110","author":"Pierret","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"2025081210014406100_bib33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jpeds.2022.09.034","article-title":"High rate of venous thromboembolism in severe pediatric intestinal failure","volume":"253","author":"Keefe","year":"2023","journal-title":"J Pediatr"},{"issue":"5","key":"2025081210014406100_bib34","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/TP.0000000000003065","article-title":"New insights into the indications for intestinal transplantation: consensus in the year 2019","volume":"104","author":"Kaufman","year":"2020","journal-title":"Transplantation"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/15\/3824\/2404567\/blooda_adv-2025-016135-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/15\/3824\/2404567\/blooda_adv-2025-016135-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T14:57:42Z","timestamp":1755010662000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/15\/3824\/536751\/Recurrent-thrombosis-and-major-bleeding-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":34,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016135","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8,12]]},"published":{"date-parts":[[2025,7,28]]}}}